Philadelphia Kratom Hearing Thursday May 21 — Bill 260163 Contains a Hidden De Facto Ban — Comment by Wednesday 3 PM
Pennsylvania community — this is happening Thursday.
Philadelphia's Bill 260163 looks like regulation on the surface — it includes a 2% 7-OH cap, lab testing, labeling requirements, and a 21+ age restriction. But buried in Section 9-6702(4) is a provision that effectively bans all natural kratom in the city.
The bill requires FDA approval under Section 505 of the Federal Food, Drug, and Cosmetic Act for all kratom products. Section 505 is a pharmaceutical drug approval process — it does not apply to natural botanical products. No natural kratom product can satisfy this standard. In practice, no kratom retailer could obtain the required license. The result is a total ban through the back door.
The hearing is Thursday May 21 at 12:00 PM, Room 400, City Hall, Philadelphia.
The most impactful action:
▪ Sign up to speak by calling (215) 686-3406 or emailing chiefclerk@phila.gov by Wednesday May 20 at 3 PM.
▪ Submit written comments to chiefclerk@phila.gov — preferably as a PDF — by Wednesday at 3 PM.
▪ Show up day-of and check in at the desk. ▪ Share your personal story.
Suggested message: "Please oppose the FDA drug approval requirement in Section 9-6702(4). This standard does not apply to natural botanical products and creates a de facto ban on natural kratom in Philadelphia. Support targeted regulation instead — age restrictions, lab testing, and clear labeling."
👉 Full details + contacts: https://getsuperleaf.com/4v2Nnq2
Please upvote and share so every Pennsylvania kratom consumer sees this before Wednesday's deadline.